It can be seen that this alkaloid can be considered to inhibit the occurrence of intracellular NFTs caused by tau hyperphosphorylation, but has no effect on other clinical features of AD, and is a potential drug for the treatment of AD. This evidence concerns the gene MAPT and Alzheimer disease.